Skip to main content
TipRanks
Go Ultimate75% OFF

Draegerwerk AG & Co. KGaA (DRW3) AI Stock Analysis

0 Followers
CH:DRW3

Draegerwerk AG & Co. KGaA

(Six Swiss:DRW3)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Recurring Lifecycle RevenueDräger’s equipment creates an installed base that can support recurring demand for consumables, replacement parts, maintenance, and regulatory services. This lifecycle model can improve customer retention and revenue visibility while making each initial sale a platform for longer-term commercial relationships.
Negative Factors
Historically Volatile Cash ConversionThe sharp historical variation in cash generation indicates that reported profitability does not always translate consistently into cash. Although current TTM figures are healthy, renewed volatility could reduce funding flexibility, complicate investment planning, and make results less predictable over the next several quarters.

Draegerwerk AG & Co. KGaA (DRW3) vs. iShares MSCI Switzerland ETF (EWL)

-20%0%20%40%60%80%100%CH:DRW3+83.87%EWL+14.15%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CHF 1.50B
Dividend Yield
1.96%
Average Volume (3M)
―
Price to Earnings (P/E)
12.1
Beta (1Y)
0.19
Revenue Growth
―
EPS Growth
―
Country
Switzerland
Employees
16,687
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Draegerwerk AG & Co. KGaA Business Overview & Revenue Model

Company Description

Headquartered in Lübeck, Germany, and established in 1889, Drägerwerk AG & Co. KGaA is an international enterprise specializing in medical and safety technology, with operations spanning Europe, the Americas, Africa, Asia, and Australia. For the heal...

Draegerwerk AG & Co. KGaA Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

CH:DRW3 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:SHLDE:SHL77OutperformEUR 47.91B21.9811.72%2.30%1.09%3.52%
DE:AFXDE:AFX73OutperformEUR 3.02B20.605.52%1.60%-0.06%-38.81%
DE:EUZDE:EUZ69NeutralEUR 864.77M17.4119.49%1.58%4.42%35.68%
DE:SBSDE:SBS61NeutralEUR 303.90M-653.75-0.17%2.29%――
DE:COPDE:COP53NeutralEUR 1.50B43.424.19%1.74%――
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%50%CH:DRW3DE:AFXDE:COPDE:EUZDE:SBSDE:SHLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:DRW3 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CH:DRW3Draegerwerk AG & Co. KGaA106.6048.6283.87%
DE:AFXCarl Zeiss Meditec34.40-8.26-19.36%
DE:COPCompuGroup Medical28.355.2122.49%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik13.93-2.68-16.14%
DE:SBSSTRATEC Biomedical26.155.6127.31%
DE:SHLSiemens Healthineers43.521.222.88%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.